Prostate Cancer - Results from #21020

EAU 2014 - Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase and prostate-specific antigen in patients with castration-resistant prostate cancer and symptomatic bone metastases from the phase 3 ALSYMPCA trial - Session Highlights April 15, 2014

Long-term survival of participants in the Prostate Cancer Prevention Trial, Silberstein and Sartor - Abstract April 14, 2014

Depression and anxiety in prostate cancer: A systematic review and meta-analysis of prevalence rates - Abstract April 14, 2014

Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise - Abstract April 14, 2014

Pre-screening age African-American males: What do they know about prostate cancer screening, knowledge, and risk perceptions? - Abstract April 14, 2014

A novel randomised controlled trial design in prostate cancer - Abstract April 14, 2014

The dosimetric effects of photon energy on the quality of prostate volumetric modulated arc therapy - Abstract April 14, 2014

A feasibility study of magnetic resonance electrical impedance tomography for prostate cancer detection - Abstract April 14, 2014

How accurately can MRI detect indolent disease? - Abstract April 14, 2014

Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer - Abstract April 14, 2014

Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer - Abstract April 14, 2014

Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy - Abstract April 11, 2014

Can MRI replace serial biopsies in men on active surveillance for prostate cancer? - Abstract April 11, 2014

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: Comparison of toxicity - Abstract April 11, 2014

Recent advances in treatment of patients with castration-resistant prostate cancer after docetaxel failure - Abstract April 11, 2014

Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL - Abstract April 11, 2014

Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: Phase I/II randomized placebo-controlled trial - Abstract April 11, 2014

4D ultrasound speckle tracking of intra-fraction prostate motion: A phantom-based comparison with x-ray fiducial tracking using CyberKnife - Abstract April 11, 2014

Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer - Abstract April 11, 2014

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer - Abstract April 11, 2014

Page 1052 of 1447